1 / 25

Leverafwijkingen tijdens de zwangerschap.

Leverafwijkingen tijdens de zwangerschap. H. Reynaert, M.D., Ph.D. Dienst Gastroenterologie-hepatologie, UZ Brussel. Laboratory liver cell biology (LIVR), VUB. Introduction. 3-5% of pregnant women have abnormal liver tests. Pre-existing liver disease. Co-incidental liver disease.

bradshawp
Download Presentation

Leverafwijkingen tijdens de zwangerschap.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Leverafwijkingen tijdens de zwangerschap. H. Reynaert, M.D., Ph.D. Dienst Gastroenterologie-hepatologie, UZ Brussel. Laboratory liver cell biology (LIVR), VUB.

  2. Introduction. • 3-5% of pregnant women have abnormal liver tests. • Pre-existing liver disease. • Co-incidental liver disease. • Pregnancy-related. • Significant maternal/fetal morbidity/mortality • Early diagnosis and treatment. Hepatology 2008; 47: 1067-76.

  3. Disorders unrelated to pregnancy • Pre-existing disease • Chronic hepatitis B, C • Auto-immune hepatitis • Cirrhosis/ portal hypertension • Transplantation • Co-incidental disease • Acute viral hepatitis (A, B, C, D, E, CMV, EBV, HSV) • Gallstone disease • Vascular disorders (Budd-Chiari) • Toxic (drugs/herbals) Lancet. 2010; 375: 594-605.

  4. Disorders “unique” to pregnancy • (Pre)-eclampsia-associated • (Pre)-eclampsia • HELPP syndrome • Acute fatty liver of pregnancy (AFL) • No association with pre-eclampsia • Hyperemesis gravidarum • Intra-hepatic cholestasis of pregnancy (ICP) Lancet. 2010; 375: 594-605.

  5. Hemolysis Elevated Liver tests Low Platelets • 0.5% of pregnancies • 85% clear association with pre-eclampsia • 2-10% of pre-eclampsia • Indication of severe disease • Different presentation of same disease? • Usually 3rd trimester or after delivery BMC Pregnancy and Childbirth 2009, 9:8-; Dig Dis Sci 2008, 53:2334–

  6. HELLP Am J Obstet Gynecol. 2000; 183: 444-8.

  7. Diagnosis HELLP syndrome. • Hemolysis • Microangiopatic hemolitic anemia • Endothelial damage & dysfunction • Abnormal implantation of trophoblast • Angiogenic-antiangiogenic imbalance no low systemic vascular resistance • Destruction of RBC • Blood smear: • Schizocytes, Burr cells, reticulocytes • LDH (>600IU/ml), unconjugated bili, haptoglobin • AST or ALT > 70 IU/ml • Low platelets: • Consumption • <100.000 /μL • INR: Normal BMC Pregnancy and Childbirth 2009, 9:8-; Dig Dis Sci 2008, 53:2334–

  8. Management. • ICU: fetal and maternal monitoring • AHT, seizures, Renal failure • DIC, ARDS • Abruptio placentae • Liver hematoma, rupture • Severe pain, fever, shock .. • MRI • Treatment: Angiography, surgery • Delivery • After 34 wks • Before 34 wks • Corticosteroids 24-48h? • Immediate if deterioration • Caesarian 50% BMC Pregnancy and Childbirth 2009, 9:8-; Dig Dis Sci 2008, 53:2334–

  9. Acute fatty liver of pregnancy (AFLP) • Rare: 1/7000-1/16.000 • 3rd trimester • ACUTE CATASTROPHY • Hepatic failure • Encephalopathy • Microvesicular fatty infiltration of hepatocytes • “Yellow atrophy of the liver” Lancet. 2010; 375: 594-605. Can J Gastroenterol 2006;20:25-30

  10. AFLP Lancet. 2010; 375: 594-605.

  11. Mitochondrialβoxidation of fattyacids. Lancet. 2010; 375: 594-605.

  12. Clinical features. Can J Gastroenterol 2006;20:25-30

  13. Can J Gastroenterol 2006;20:25-30

  14. Management. • ICU • Monitoring + stabilization • Hemodynamic • Encephalopathy • Renal function • Metabolic (hypoglycemia) • Coagulation • Pancreatitis • Delivery: emergency! • Never recovery without delivery Can J Gastroenterol 2006;20:25-30

  15. Outcome. • Mother: • Mortality: 7-20% • Bleeding, pancreatitis, liver failure, sepsis • Recovery • Immediately or late (1 wk) • Prolonged cholestasis (several wks) • Eventually complete • Recurrence • Theoretically 25% • Child: • Mortality: 10-25% Can J Gastroenterol 2006;20:25-30

  16. Hyperemesis gravidarum • 0,3-2% pregnancies • First trimester • Wks 4-18 • Etiology?: unclear. • Motility? Hormonal? Beta-hCG? Leptin? …. • Intractable vomiting, dehydration, weight loss > 5% • Risk factors • Diabetes, obesity, multiple pregnancies, young, … • Lab results: • Hyperthyroidism 60% • Abnormal (50%) ALT > AST up to 20 x ULN • Increased peripheral lipolysis  FFA  liver injury?? • Jaundice is rare Dig Dis Sci 2008, 53:2334–;Lancet. 2010; 375: 594-605.

  17. Hyperemesis gravidarum • Treatment • Rehydration IV, short period fasting • Vitamin supplements (Thiamine) • Small, frequent meals • Diet rich in carbohydrates, low fat • Anti-emetics • Phenergan, primperan • Enteral, (parenteral) feeding • Outcome • Mother • Good • Fetus • Slightly increased congenital abnormalities? Lancet. 2010; 375: 594-605; Dig Dis Sci 2008, 53:2334– .

  18. Intra-hepatic Cholestasis of Pregnancy • Prevalence <1% in W-Europe • Pathophysiology: incompletely understood • Genetic factors • Bile transporters • Hormonal • Estrogens/progesterone • Environmental • selenium? Orphanet Journal of Rare Diseases 2007, 2: 26-

  19. Intra-hepatic Cholestasis of Pregnancy Lancet. 2010; 375: 594-605.

  20. Clinical manifestations • Pruritus • Mild  very severe • Palms/soles • > 25-30 wks (as early as 6 wks) • Jaundice • Usually later Orphanet Journal of Rare Diseases 2007, 2: 26-

  21. Biochemical abnormalities • bile acids: x10-100 • Fasting serum bile acids > 10μmol/L = diagnostic • ALT: <10x, sometimes > 20x • GGT: normal-slightly elevated • Bilirubin: nl-mildly elevated • Vit K deficiencey Orphanet Journal of Rare Diseases 2007, 2: 26-

  22. Treatment: Ursodeoxycholic acid (UDCA). Gastroenterology 2005, 129: 894-901

  23. Outcome. • Fetal • Preterm delivery (19-60%), mortality (0,4-4%), … • Associated with increasing fasting serum levels of bile acids (>40 μmol/L) • Good when treated with UDCA • Maternal • Good • Resolves after delivery Orphanet Journal of Rare Diseases 2007, 2: 26 -

  24. Conclusions. • Not all abnormal liver tests are caused by pregnancy-related diseases. • Non-pregnancy related liver diseases should be ruled out! • Toxic & drug-induced hepatitis • Viral hepatitis • Biliary disease • Budd-Chiari • Etc.

  25. Conclusions. Hepatology 2008; 47: 1067-76.

More Related